Literature DB >> 20937022

Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity.

P Collini1, M Noursadeghi, I Sabroe, R F Miller, D H Dockrell.   

Abstract

HIV-1 can establish both long lived and productive infection of macrophages (Mϕ) but circulating monocytes are less permissive to infection. Multiple studies have identified extensive changes to monocyte and Mϕ phenotype, differentiation or function. These include alterations in Toll-like receptor signaling and resultant changes to cytokine responses, specific defects in phagocytosis and microbial killing and modulation of apoptotic responses, all of which may perturb the important role of these cells in innate immunity. Interpretation of contradictory data however, is complicated by the use of different experimental models and many of the reported effects may be an indirect consequence of HIV 1 infection that result from exposure to viral products or from disruption of cellular and cytokine networks in the immune system, rather than the direct consequence of productive HIV 1 infection. Future research should focus on refining experimental models and on elucidating the physiological mechanisms of monocyte/ Mϕ dysfunction during HIV 1 infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937022     DOI: 10.2174/156652410793384141

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  20 in total

1.  Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms.

Authors:  Elizabeth C Delery; Andrew G MacLean
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

Review 2.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

3.  Macrophages Are Phenotypically and Functionally Diverse across Tissues in Simian Immunodeficiency Virus-Infected and Uninfected Asian Macaques.

Authors:  Alexandra M Ortiz; Sarah R DiNapoli; Jason M Brenchley
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

4.  HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci.

Authors:  Paul J Collini; Martin A Bewley; Mohamed Mohasin; Helen M Marriott; Robert F Miller; Anna-Maria Geretti; Apostolos Beloukas; Athanasios Papadimitropoulos; Robert C Read; Mahdad Noursadeghi; David H Dockrell
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 5.  Pneumococcal pneumonia: mechanisms of infection and resolution.

Authors:  David H Dockrell; Moira K B Whyte; Timothy J Mitchell
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

Review 6.  Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Authors:  Nursel Calik Basaran; Sibel Ascioglu
Journal:  Ther Adv Infect Dis       Date:  2017-10-17

Review 7.  Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies.

Authors:  Elizabeth J Polvi; Xinliu Li; Teresa R O'Meara; Michelle D Leach; Leah E Cowen
Journal:  Cell Mol Life Sci       Date:  2015-02-21       Impact factor: 9.261

Review 8.  Viral determinants of HIV-1 macrophage tropism.

Authors:  Christopher J A Duncan; Quentin J Sattentau
Journal:  Viruses       Date:  2011-11-15       Impact factor: 5.048

9.  Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics.

Authors:  João Manoel Silva; Sigrid De Sousa dos Santos
Journal:  J Int AIDS Soc       Date:  2013-01-30       Impact factor: 5.396

10.  Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy.

Authors:  Jing Qin Wu; Tara Ruth Sassé; Monica Miranda Saksena; Nitin K Saksena
Journal:  Virol J       Date:  2013-12-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.